1. Home
  2. DTCK vs UBX Comparison

DTCK vs UBX Comparison

Compare DTCK & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTCK
  • UBX
  • Stock Information
  • Founded
  • DTCK 1999
  • UBX 2009
  • Country
  • DTCK Singapore
  • UBX United States
  • Employees
  • DTCK N/A
  • UBX N/A
  • Industry
  • DTCK Farming/Seeds/Milling
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTCK Industrials
  • UBX Health Care
  • Exchange
  • DTCK Nasdaq
  • UBX Nasdaq
  • Market Cap
  • DTCK 19.3M
  • UBX 13.8M
  • IPO Year
  • DTCK 2023
  • UBX 2018
  • Fundamental
  • Price
  • DTCK $0.82
  • UBX $0.20
  • Analyst Decision
  • DTCK
  • UBX Strong Buy
  • Analyst Count
  • DTCK 0
  • UBX 3
  • Target Price
  • DTCK N/A
  • UBX $4.67
  • AVG Volume (30 Days)
  • DTCK 562.9K
  • UBX 1.8M
  • Earning Date
  • DTCK 04-30-2025
  • UBX 08-05-2025
  • Dividend Yield
  • DTCK N/A
  • UBX N/A
  • EPS Growth
  • DTCK N/A
  • UBX N/A
  • EPS
  • DTCK N/A
  • UBX N/A
  • Revenue
  • DTCK $132,369,000.00
  • UBX N/A
  • Revenue This Year
  • DTCK N/A
  • UBX N/A
  • Revenue Next Year
  • DTCK N/A
  • UBX N/A
  • P/E Ratio
  • DTCK N/A
  • UBX N/A
  • Revenue Growth
  • DTCK N/A
  • UBX N/A
  • 52 Week Low
  • DTCK $0.40
  • UBX $0.20
  • 52 Week High
  • DTCK $1.50
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • DTCK 55.64
  • UBX 18.68
  • Support Level
  • DTCK $0.73
  • UBX $0.24
  • Resistance Level
  • DTCK $0.86
  • UBX $0.83
  • Average True Range (ATR)
  • DTCK 0.11
  • UBX 0.08
  • MACD
  • DTCK -0.01
  • UBX -0.05
  • Stochastic Oscillator
  • DTCK 19.04
  • UBX 0.00

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: